Nov. 18 at 6:30 PM
$MXCT
Not all acquisitions are viewed favorably by shareholders.
Take
$SCPH as an example. Sold at 5.67 per share with CVRs allowing it to increase the purchase price to somewhere over
$6, I believe (please check this to confirm as I don't remember the particulars).
If you bought scph in the high 1s around March or April of this year (I forget exactly - check the chart), or if you bought it in the 2s or 3s before its run after the Q2 ER, you are likely not complaining about the windfall of gains.
But if you were a longer term holder, this could be viewed as disappointing as you may have been in the stock with an average price close to the buyout price.
I believe this same thing may apply to
$MXCT as anyone who bought between August 7th and last week (or even up to today, arguably) would be very happy with an acquisition between 2.60-3.60 as that would be a great, fast win; but longterm holders might be disappointed because their average cost per share may be higher...
